Cinctive Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.37M Buy
68,615
+35,905
+110% +$2.9M 0.2% 164
2026
Q1
$2.83M Buy
32,710
+11,696
+56% +$1.12M 0.18% 172
2025
Q4
$2.02M Buy
+21,014
New +$2.04M 0.11% 211
2022
Q2
Sell
-75,583
Closed -$8.39M 587
2022
Q1
$8.39M Buy
+75,583
New +$7.99M 0.31% 100
2021
Q4
Sell
-89,372
Closed -$11.2M 608
2021
Q3
$11.2M Buy
89,372
+82,297
+1,163% +$10.7M 0.55% 33
2021
Q2
$878K Sell
7,075
-37,216
-84% -$4.67M 0.04% 379
2021
Q1
$5.23M Buy
44,291
+28,864
+187% +$3.38M 0.32% 108
2020
Q4
$1.81M Sell
15,427
-94,156
-86% -$10.4M 0.15% 234
2020
Q3
$11.4M Buy
+109,583
New +$11M 1% 9

Other funds holding MDT

Cinctive Capital Management's MDT Position: Q2 2026 in Review

Cinctive Capital Management increased its Medtronic (MDT) stake by 110% in Q2 2026, buying an estimated $2.9M and bringing the position to 68,615 shares worth $5.37M. The position accounts for 0.2% of the portfolio, ranked #164.

Cinctive Capital Management first reported a position in MDT in Q3 2020 and has held it in 9 quarters since. The position peaked at $11.4M in Q3 2020. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Cinctive Capital Management held 68,615 shares of Medtronic worth $5.37M as of Q2 2026.
  • Cinctive Capital Management bought 35,905 Medtronic shares in Q2 2026, an estimated $2.9M.
  • Medtronic made up 0.2% of Cinctive Capital Management's portfolio in Q2 2026, its #164 holding.
  • Cinctive Capital Management first reported a position in Medtronic in Q3 2020 and has held it in 9 quarters since.
  • Cinctive Capital Management's Medtronic position peaked at $11.4M in Q3 2020.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Cinctive Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.